BioROSA Technologies is developing biologically-based diagnostic tools for Autism Spectrum Disorder (ASD), aiming to make ASD diagnosis rapid and simple. The company's approach focuses on using biomarkers and metabolite panels (including FOCM/TS metabolites) to create a clinical standard of care for autism diagnosis. BioROSA has partnered with academic and clinical research institutions including the BRAIN Foundation and O'Sullivan Foundation, contributing to translational clinical studies published in peer-reviewed journals.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2022
Jan 2018
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
